Reporting owner · CIK 0001886794

Dhaliwal Harpreet S.

Visual SEC Form 4 history across 1 companies, 3 transactions and 2 filings.

CTOOChief Technical Ops OfficerVaxcyte, Inc.
Open-market mix
Filings2Form 4 records
Buying$00 purchases
Selling$454.9K1 sales
Net value−$454.9KBuys minus sells
Companies11 securities
Most recentSep 02, 2026withholding

Open-market buy performance

90-day forward return on this insider's open-market purchases

90d forward
Forward return is not available yet

We compute this from each buy's stock performance 90 days after the transaction. The price history is still being populated for this insider's their open-market buys, so the average and median will appear here once the daily price refresh has covered the relevant trading days.

Monthly open-market activity

Reported purchase and sale transaction counts

Buys Sells
530-3-51Dec 25Aug 26Sep 26

Net value flow

Buys minus sells

Dec 25
−$454.9K
Aug 26
$0
Sep 26
$0

Transaction texture

Ownership and ticket size

Average P/S size$454.9K
Median P/S size$454.9K
Direct3
Indirect0
Sep 02, 2026withholding

Filing-only signals

Deterministic matches in this insider's history

Latest Form 4 facts

Quick context from source filings

Latest transaction

sale at Vaxcyte, Inc. on Dec 31, 2025 valued at $454,891.

Review SEC filing
Latest buy

No open-market insider purchase is available.

Associated companies

Visual map of known reporting history

TickerInsiderRoleTypeSharesValueCodeSignals90d returnFiledTrans date
PCVXDhaliwal Harpreet S.
CTOO
withholding659-$4.05MF0.0%09/0209/02
PCVXDhaliwal Harpreet S.
CTOO
withholding361-$2.19MF0.0%09/0208/31
PCVXDhaliwal Harpreet S.
CTOO
sale9.74k-$45.4MS+25.9%01/0212/31/2025

Dhaliwal Harpreet S. Insider Activity FAQ

SEC Form 4 context

Who is Dhaliwal Harpreet S.?

Dhaliwal Harpreet S. is a reporting owner in SEC Form 4 filings with reporting owner CIK 0001886794.

Which companies has Dhaliwal Harpreet S. reported transactions for?

Vaxcyte, Inc.

When was Dhaliwal Harpreet S.'s latest insider buy?

No open-market insider purchase is available for this period.

When was Dhaliwal Harpreet S.'s latest insider sale?

sale at Vaxcyte, Inc. on Dec 31, 2025 valued at $454,891.

Where can I see the original SEC filings?

Each transaction row links directly to the source SEC filing so the reported Form 4 details can be reviewed.

Are performance metrics included?

This version does not calculate win rates, forward returns, benchmark-adjusted returns, or high-conviction scores.